Patents by Inventor Tamara HILMENYUK

Tamara HILMENYUK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Approach for Treating Cancer
    Publication number: 20200009181
    Abstract: The present invention relates to a novel approach for treating cancer, which is based on targeting PD-L1 mRNA. The invention is directed to oligonucleotides comprising 10 to 20 modified or unmodified nucleotides complementary to specifically selected regions of the PD-L1.
    Type: Application
    Filed: October 6, 2017
    Publication date: January 9, 2020
    Inventors: Tamara HILMENYUK, Frank JASCHINSKI, Richard KLAR
  • OLIGONUCLEOTIDES INHIBITING THE EXPRESSION OF NRP1
    Publication number: 20190330640
    Abstract: The present invention refers to an oligonucleotides comprising 12 to 18 nucleotides, wherein at least one of the nucleotides is modified, and the oligonucleotide hybridizes with a nucleic acid sequence of neuropilin 1 (NRP1, CD304) of SEQ ID NO.1 (NM_003873.5), wherein the oligonucleotide inhibits at least 50% of the NRP1 expression. The invention is further directed to a pharmaceutical composition comprising such oligonucleotide.
    Type: Application
    Filed: January 9, 2018
    Publication date: October 31, 2019
    Inventors: Frank JASCHINSKI, Tamara HILMENYUK, Sven MICHEL